Details for New Drug Application (NDA): 208643
✉ Email this page to a colleague
NDA 208643 describes PALIPERIDONE, which is a drug marketed by Actavis Labs Fl Inc, Ajanta Pharma Ltd, Alembic, Amneal Pharms, Ascent Pharms Inc, Cspc Ouyi, Inventia, Lupin Ltd, Rk Pharma, Sun Pharm, Zydus Pharms, and Teva Pharms Usa, and is included in twelve NDAs. It is available from seventeen suppliers. Additional details are available on the PALIPERIDONE profile page.
The generic ingredient in PALIPERIDONE is paliperidone palmitate. There are thirty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the paliperidone palmitate profile page.
The generic ingredient in PALIPERIDONE is paliperidone palmitate. There are thirty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the paliperidone palmitate profile page.
Summary for 208643
| Tradename: | PALIPERIDONE |
| Applicant: | Lupin Ltd |
| Ingredient: | paliperidone |
| Patents: | 0 |
Suppliers and Packaging for NDA: 208643
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PALIPERIDONE | paliperidone | TABLET, EXTENDED RELEASE;ORAL | 208643 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-523 | 68180-523-06 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-523-06) |
| PALIPERIDONE | paliperidone | TABLET, EXTENDED RELEASE;ORAL | 208643 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-524 | 68180-524-06 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68180-524-06) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 1.5MG | ||||
| Approval Date: | Jun 29, 2022 | TE: | BX | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 3MG | ||||
| Approval Date: | Jun 29, 2022 | TE: | BX | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 6MG | ||||
| Approval Date: | Jun 29, 2022 | TE: | BX | RLD: | No | ||||
Complete Access Available with Subscription
